Antiplatelet Drugs- Are Physicians "Nonresponders" When it Comes to Testing?: Neuro Notes
Links shared publicly online about this topic.
- 1,308total visits
Antiplatelet Drugs- Are Physicians "Nonresponders" When it Comes to Testing?: Neuro Notes
View full resource at boards.medscape.com
Tags: Neurology, Disease and Condition, Anti-Clotting Medication, Plavix, Aspirin, Physician
Most Recently Shared on March 17, 2010 at 7:54 pm By:
Antiplatelet Drugs- Are Physicians "Nonresponders" When it Comes to Testing?: Neuro Notes: http://bit.ly/dz9IaJ via @addthis
Buy Tadalista (Tadalafil) 2.5mg, 5mg, 10mg, 20mg, 40mg, Tadalista CT at Low Cost
internationaldrugmart.com — “Order Tadalista, Tadalista ct, Tadalista sublingual tablets are used for impotence and erectile dysfunction. Order and save upto $46.16.” View full resource at internationaldrugmart.com
Most Recently Shared on March 28, 2012 at 2:32 am By:
Medscape - Medscape Photo Contest | Facebook
facebook.com — “Medscape - With Medscape, you can stay current with breaking medical news; quickly look up drugs, diseases, and procedures; complete free continuing medical education activities; and connect with your colleagues. Get free, unlimited access at - Company Overview: Medscape is the leading online destination for clinical information and educational resources for physicians and other healthcare professionals. ______________________________________________________ - Description: We offer free... | Fac” View full resource at facebook.com
Most Recently Shared on March 27, 2012 at 3:32 pm By:
Medscape Radiology Health Site
Chance to win the new Apple iPad in Medscape’s Photo Contest! Submit an original photo of your favorite hobby. http://t.co/InnHHLvo
Cardiovascular Business ACC: Triple-antiplatelet therapy is non-inferior to double-dose of dual antiplatelets
cardiovascularbusiness.com — “CHICAGO—A popular three-pronged drug approach in Asia that adds chilostazol to dual antiplatelet therapy had comparable outcomes to a double-dose dual antiplatelet regimen, according to the results of the late-breaking HOST-ASSURE clinical trial presented March 25 at the 61st annual American College of Cardiology (ACC) scientific session.” View full resource at cardiovascularbusiness.com
Most Recently Shared on March 26, 2012 at 7:00 pm By:
CardioBusiness Health Magazine
Triple-antiplatelet therapy is non-inferior to double-dose of dual antiplatelet http://t.co/rJzCG3gu #ACC12 #antiplatelet #HOST-ASSURE
Experimental blood thinning drug shows mixed results; Vorapaxar works differently than aspirin or coumadin - NY Daily News
nydailynews.com — “The latest data further clouds the future for Vorapaxar, an anti-platelet medicine that works differently than aspirin or the popular blood thinner coumadin.” View full resource at nydailynews.com
Most Recently Shared on March 26, 2012 at 6:06 pm By:
Blood thinning drug shows mixed results: The latest data further clouds the future for Vorapaxar, an anti-platel... http://t.co/8JmATpyP
Caution Urged in Moving More Drugs OTC : ACEP NEWS
acepnews.com — “ACEP News offers real-time clinical news, news from the American College of Emergency Physicians, and news on practice trends and health care reform for the emergency medicine physician. Features include In The Arena by Dr. David Baehren, the CME feature called Focus On, and the practical guide to ED procedures called Tricks of the Trade. Specialty Focus items include Cardiovascular Disorders, Dermatologic Disorders, Imaging, Infectious Diseases, Metabolic & Endocrine Disorders, Neurologic Disor” View full resource at acepnews.com
Most Recently Shared on March 26, 2012 at 4:16 pm By:
Nancy Calaway Medical Society and Medical Journal
Caution Urged in Moving More Drugs OTC: Although expanding nonprescription access to some medications could be b... http://t.co/qwyuuPgC
Pharma scales back drug samples to physician offices - amednews.com
ama-assn.org — “Pharma scales back drug samples to physician offices - amednews.com” View full resource at ama-assn.org
Most Recently Shared on March 26, 2012 at 3:09 pm By:
AmericanMedicalNews Health Organization and Health News
Good #MobileMorning: Pharma scales back drug samples to physician offices http://t.co/xeCKVPKH
Implementation Science | Abstract | A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplate
implementationscience.com — “High-risk prescribing of non-steroidal anti-inflammatory drugs (NSAIDs) and antiplatelet agents accounts for a significant proportion of hospital admissions due to preventable adverse drug events. The recently completed PINCER trial has demonstrated that a one-off pharmacist-led information technology (IT)-based intervention can significantly reduce high-risk prescribing in primary care, but there is evidence that effects decrease over time and employing additional pharmacists to facilitate chan” View full resource at implementationscience.com
Most Recently Shared on March 26, 2012 at 3:00 pm By:
BioMed Central Medical Journal
RT @implementsci: Protocol | Reducing high-risk prescribing of NSAIDs and antiplatelets in primary care: cluster RCT | http://t.co/u6jwZfXl
Drugs Affect Quality of Life - The People's Pharmacy®
peoplespharmacy.com — “Drug Benefits, Risks and Interactions” View full resource at peoplespharmacy.com
Most Recently Shared on March 26, 2012 at 2:48 pm By:
The Peoples Pharmacy Health Site
Drugs Affect Quality of Life - Physicians assess treatment success by looking at numbers. Blood pressure, cholestero... http://t.co/uXWKmjGH
Pharma scales back drug samples to physician offices - amednews.com
ama-assn.org — “Pharma scales back drug samples to physician offices - amednews.com” View full resource at ama-assn.org
Most Recently Shared on March 26, 2012 at 11:45 am By:
Pharma scales back drug samples to physician offices -- http://t.co/fsuFzpAw #hcsm #socpharm #mHealth #epharma #hcmktg #pharmamktg
Pharma scales back drug samples to physician offices - amednews.com
ama-assn.org — “Pharma scales back drug samples to physician offices - amednews.com” View full resource at ama-assn.org
Most Recently Shared on March 26, 2012 at 6:31 am By:
Paul Abramson MD Physician, Doctor, Active Health Library, CAM, Family Medicine Doctor, and Integrative Physician
Why not just ban drug reps and samples? RT @amednews: Pharma scales back drug samples to physician offices http://t.co/Cr4cP9iu
Novel Antiplatelet Agent Reduces CV Events But Increases Bleeding - Forbes
forbes.com — “Vorapaxar, the novel antiplatelet agent from Merck, appears to effectively reduce cardiovascular death and ischemic events in patients with MI, ischemic stroke, or peripheral vascular disease, but its potential utility is clouded by bleeding complications, including intracranial hemorrhage. Results from the TRA 2P-TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of [...]” View full resource at forbes.com
Most Recently Shared on March 24, 2012 at 2:07 pm By:
Drugs and Devices OW OW Health
Novel Antiplatelet Agent Reduces CV Events But Increases Bleeding: Vorapaxar, the novel antiplatelet agent... http://t.co/UiSxUrWH #drug
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “The American College of Physicians has issued a guideline that provides three clinical recommendations regarding the comparative effectiveness and safety of type 2 diabetes medications. The guideline specifically addresses the pharmacologic management of patients with type 2 diabetes using agents from any of 11 unique classes of drugs available to treat hyperglycemia in these patients.” View full resource at aafp.org
Most Recently Shared on March 23, 2012 at 6:37 pm By:
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy http://t.co/PBkWUXwH
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “The American College of Physicians has issued a guideline that provides three clinical recommendations regarding the comparative effectiveness and safety of type 2 diabetes medications. The guideline specifically addresses the pharmacologic management of patients with type 2 diabetes using agents from any of 11 unique classes of drugs available to treat hyperglycemia in these patients.” View full resource at aafp.org
Most Recently Shared on March 23, 2012 at 6:17 pm By:
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy: The American College of Ph... http://t.co/eccl3Dmt
Brilliant Blue G Compounded by Franck's: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases
fda.gov — “UPDATED 03/21/2012. Reports of eye infections in patients who were given Brilliant Blue G during eye surgeries.” View full resource at fda.gov
Most Recently Shared on March 23, 2012 at 5:36 pm By:
FDA Recall of Unapproved Drug; physicians warned against using Brilliant Blue for Eye Surgery. http://t.co/2pYjvDNB
New Drug Use Consequences Test For Primary Care Physicians Validated By Researchers
medicalnewstoday.com — “Researchers from the Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have conducted a study on a modified version of the Short Inventory of Proble” View full resource at medicalnewstoday.com
Most Recently Shared on March 23, 2012 at 7:05 am By:
MNT Alcohol / Addict Health News
New Drug Use Consequences Test For Primary Care Physicians Validated By Researchers http://t.co/TsK0NvU3 #alcohol #addiction
Advertisement
